Salveen Richter
Stock Analyst at Goldman Sachs
(3.59)
# 822
Out of 5,147 analysts
207
Total ratings
43.86%
Success rate
8.35%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Maintains: Neutral | $36 → $41 | $53.57 | -23.46% | 11 | Feb 17, 2026 | |
| AGIO Agios Pharmaceuticals | Maintains: Neutral | $40 → $25 | $30.23 | -17.30% | 10 | Nov 20, 2025 | |
| FOLD Amicus Therapeutics | Maintains: Neutral | $9 → $11 | $14.37 | -23.45% | 3 | Nov 5, 2025 | |
| QURE uniQure | Maintains: Neutral | $56 → $38 | $15.63 | +143.12% | 9 | Nov 4, 2025 | |
| RCUS Arcus Biosciences | Maintains: Neutral | $14 → $16 | $20.37 | -21.45% | 4 | Oct 30, 2025 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $45 → $65 | $81.15 | -19.90% | 5 | Sep 26, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Sell | $26 → $18 | $20.96 | -14.12% | 9 | Sep 26, 2025 | |
| IMNM Immunome | Initiates: Buy | $26 | $21.86 | +18.94% | 1 | Sep 22, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $504 → $566 | $332.92 | +70.01% | 6 | Sep 16, 2025 | |
| FDMT 4D Molecular Therapeutics | Maintains: Buy | $44 → $38 | $9.66 | +293.37% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $19 | $16.76 | +13.37% | 6 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $15 → $17 | $24.56 | -30.78% | 9 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $29.69 | +24.62% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $47 | $60.14 | -21.85% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $124 → $104 | $61.73 | +68.48% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $41 | $16.59 | +147.14% | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $10 | $16.02 | -37.58% | 11 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $917 → $804 | $781.67 | +2.86% | 11 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $219 → $197 | $191.82 | +2.70% | 4 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $18 | $10.26 | +75.44% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $96 | $148.95 | -35.55% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $21.18 | +88.86% | 5 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $12 | $13.78 | -12.92% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $82 → $72 | $97.41 | -26.09% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $101.27 | -30.88% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $23.39 | +224.93% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $388.16 | -9.83% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $496.83 | +12.51% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $26.86 | -81.38% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $2.78 | +1,015.11% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $245.87 | -8.49% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $4.62 | +376.19% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $24.00 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.20 | +614.29% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $3.67 | +145.23% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $4.53 | -33.77% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.21 | +42.52% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $70.86 | -39.32% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $3.88 | -48.45% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $5.42 | +1,745.02% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $560 → $600 | $9.12 | +6,478.95% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $126.09 | -60.35% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $63.27 | -28.88% | 1 | Mar 17, 2020 |
Moderna
Feb 17, 2026
Maintains: Neutral
Price Target: $36 → $41
Current: $53.57
Upside: -23.46%
Agios Pharmaceuticals
Nov 20, 2025
Maintains: Neutral
Price Target: $40 → $25
Current: $30.23
Upside: -17.30%
Amicus Therapeutics
Nov 5, 2025
Maintains: Neutral
Price Target: $9 → $11
Current: $14.37
Upside: -23.45%
uniQure
Nov 4, 2025
Maintains: Neutral
Price Target: $56 → $38
Current: $15.63
Upside: +143.12%
Arcus Biosciences
Oct 30, 2025
Maintains: Neutral
Price Target: $14 → $16
Current: $20.37
Upside: -21.45%
Ionis Pharmaceuticals
Sep 26, 2025
Upgrades: Neutral
Price Target: $45 → $65
Current: $81.15
Upside: -19.90%
Apellis Pharmaceuticals
Sep 26, 2025
Downgrades: Sell
Price Target: $26 → $18
Current: $20.96
Upside: -14.12%
Immunome
Sep 22, 2025
Initiates: Buy
Price Target: $26
Current: $21.86
Upside: +18.94%
Alnylam Pharmaceuticals
Sep 16, 2025
Maintains: Buy
Price Target: $504 → $566
Current: $332.92
Upside: +70.01%
4D Molecular Therapeutics
Aug 12, 2025
Maintains: Buy
Price Target: $44 → $38
Current: $9.66
Upside: +293.37%
Aug 7, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $16.76
Upside: +13.37%
Aug 7, 2025
Maintains: Sell
Price Target: $15 → $17
Current: $24.56
Upside: -30.78%
Jun 16, 2025
Initiates: Buy
Price Target: $37
Current: $29.69
Upside: +24.62%
May 8, 2025
Maintains: Neutral
Price Target: $53 → $47
Current: $60.14
Upside: -21.85%
May 5, 2025
Maintains: Buy
Price Target: $124 → $104
Current: $61.73
Upside: +68.48%
May 2, 2025
Maintains: Buy
Price Target: $37 → $41
Current: $16.59
Upside: +147.14%
May 2, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $16.02
Upside: -37.58%
Apr 30, 2025
Maintains: Buy
Price Target: $917 → $804
Current: $781.67
Upside: +2.86%
Apr 23, 2025
Maintains: Buy
Price Target: $219 → $197
Current: $191.82
Upside: +2.70%
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $10.26
Upside: +75.44%
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $148.95
Upside: -35.55%
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $21.18
Upside: +88.86%
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $13.78
Upside: -12.92%
Jan 13, 2025
Maintains: Neutral
Price Target: $82 → $72
Current: $97.41
Upside: -26.09%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $101.27
Upside: -30.88%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $23.39
Upside: +224.93%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $388.16
Upside: -9.83%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $496.83
Upside: +12.51%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $26.86
Upside: -81.38%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $2.78
Upside: +1,015.11%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $245.87
Upside: -8.49%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $4.62
Upside: +376.19%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $24.00
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.20
Upside: +614.29%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $3.67
Upside: +145.23%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $4.53
Upside: -33.77%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.21
Upside: +42.52%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $70.86
Upside: -39.32%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $3.88
Upside: -48.45%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $5.42
Upside: +1,745.02%
Mar 4, 2021
Upgrades: Buy
Price Target: $560 → $600
Current: $9.12
Upside: +6,478.95%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $126.09
Upside: -60.35%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $63.27
Upside: -28.88%